UBC Executive and Leadership Team

Bekki Brown, the President & Chief Executive Officer at UBC, directs the overarching strategic vision for this global biopharmaceutical services organization. Brown architects the integration of scientific expertise with advanced data analytics to ensure medical products meet rigorous safety and efficacy standards under real-world conditions. By aligning internal research capabilities with the evolving needs of life sciences partners, the President & Chief Executive Officer drives long-term growth and market relevance. This leadership role involves constant collaboration with the Board to refine evidence development solutions that inform regulatory and payer decision-making. Overseeing the entire organizational footprint, Bekki Brown ensures that all service lines maintain high standards of clinical integrity. Through the optimization of technology-driven platforms, the President & Chief Executive Officer secures the company's position as a leader in real-world evidence generation, ultimately fostering improved healthcare outcomes across diverse international markets.

Steve Bell, the Chief Financial Officer & Acco Principal at UBC, manages the fiscal health and financial reporting structures of the organization. Bell oversees capital allocation strategies that support the expansion of evidence development services across global biopharmaceutical markets. By monitoring complex data analytics investments, the Chief Financial Officer & Acco Principal ensures that financial resources align with the company's mission to provide high-value assessment tools for medical products. This role requires close coordination with executive leadership to maintain robust internal controls and regulatory compliance. Through rigorous financial planning, Steve Bell drives operational efficiency and supports the long-term sustainability of the business model. The Chief Financial Officer & Acco Principal also evaluates market trends to identify opportunities for scaling service delivery, ensuring that the organization remains agile while navigating the financial demands of the competitive life sciences sector.

Dean Reiman, the President at UBC, executes the operational delivery of evidence development solutions across the organization's diverse service portfolio. Reiman directs the implementation of advanced data analytics and technology platforms to support the assessment of medical products in real-world settings. By overseeing the execution of clinical programs, the President ensures that pharmaceutical partners receive actionable insights that drive regulatory and commercial success. This role involves managing cross-functional teams to maintain high-quality standards in evidence generation and value assessment. Through the optimization of internal processes, Dean Reiman drives operational excellence and enhances the company's ability to address complex drug development challenges. The President also fosters collaboration with external healthcare decision-makers to ensure that service offerings remain aligned with current market needs, ultimately strengthening the organization's impact on global patient care and medical product efficacy.

Michael Haratz, the Senior Vice President, Chief Legal Officer at UBC, governs the legal framework and risk management protocols for the entire enterprise. Haratz architects comprehensive strategies to address the complex regulatory requirements inherent in biopharmaceutical services and real-world evidence generation. By providing counsel on commercialization and data privacy, the Senior Vice President, Chief Legal Officer protects the intellectual property and operational integrity of the organization. This leadership role involves navigating international legal landscapes to facilitate seamless service delivery for global life sciences partners. Through proactive risk mitigation, Michael Haratz ensures that all clinical and evidence-based initiatives adhere to strict industry standards. The Senior Vice President, Chief Legal Officer also manages contractual relationships with key stakeholders, maintaining the legal foundation necessary for the company to deliver high-impact solutions that inform critical healthcare decision-making processes worldwide.